Literature DB >> 18068258

A fast and sensitive method for measuring the integrity of siRNA-carrier complexes in full human serum.

Kevin Buyens1, Bart Lucas, Koen Raemdonck, Kevin Braeckmans, Jo Vercammen, Jelle Hendrix, Yves Engelborghs, Stefaan C De Smedt, Niek N Sanders.   

Abstract

SiRNA based therapeutics are currently under investigation for treatment of cancer and viral infections. Upon intravenous administration, the nanoscopic delivery systems which carry the siRNA need to be stable in serum, an aspect which is often overlooked in numerous publications on siRNA delivery systems. Techniques currently available for studying the dissociation of siRNA-liposome complexes are time consuming and incompatible with full serum. We therefore developed a fluorescence fluctuation spectroscopy (FFS) based method which allows to monitor the integrity of siRNA-carrier complexes. The method can very rapidly provide quantitative information on the complex integrity in biological media, like full human serum, and at very low siRNA concentrations (approximately 20 nM siRNA). Information on the integrity of intravenously injected siRNA nanoparticles in serum is crucial. Consequently, the FFS method reported in this work may find broad applicability in the field of siRNA-carrier design.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18068258     DOI: 10.1016/j.jconrel.2007.10.024

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  22 in total

1.  siRNA-mediated down-regulation of P-glycoprotein in a Xenograft tumor model in NOD-SCID mice.

Authors:  Meysam Abbasi; Hamidreza Montazeri Aliabadi; Elaine H Moase; Afsaneh Lavasanifar; Kamaljit Kaur; Raymond Lai; Charles Doillon; Hasan Uludağ
Journal:  Pharm Res       Date:  2011-06-03       Impact factor: 4.200

Review 2.  Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities.

Authors:  Jessie L-S Au; Bertrand Z Yeung; Michael G Wientjes; Ze Lu; M Guillaume Wientjes
Journal:  Adv Drug Deliv Rev       Date:  2015-12-11       Impact factor: 15.470

3.  Multiparametric approach for the evaluation of lipid nanoparticles for siRNA delivery.

Authors:  Christopher A Alabi; Kevin T Love; Gaurav Sahay; Hao Yin; Kathryn M Luly; Robert Langer; Daniel G Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-23       Impact factor: 11.205

4.  Exploring the HYDRAtion method for loading siRNA on liposomes: the interplay between stability and biological activity in human undiluted ascites fluid.

Authors:  George R Dakwar; Kevin Braeckmans; Wim Ceelen; Stefaan C De Smedt; Katrien Remaut
Journal:  Drug Deliv Transl Res       Date:  2017-04       Impact factor: 4.617

5.  New Techniques to Assess In Vitro Release of siRNA from Nanoscale Polyplexes.

Authors:  Bettina Krieg; Markus Hirsch; Erik Scholz; Lutz Nuhn; Ilja Tabujew; Heiko Bauer; Sandra Decker; Andriy Khobta; Manfred Schmidt; Wolfgang Tremel; Rudolf Zentel; Kalina Peneva; Kaloian Koynov; A James Mason; Mark Helm
Journal:  Pharm Res       Date:  2014-12-09       Impact factor: 4.200

6.  Cationic polymers for non-viral gene delivery to human T cells.

Authors:  Brynn R Olden; Yilong Cheng; Jonathan L Yu; Suzie H Pun
Journal:  J Control Release       Date:  2018-03-05       Impact factor: 9.776

Review 7.  Target Site Delivery and Residence of Nanomedicines: Application of Quantitative Systems Pharmacology.

Authors:  Jessie L-S Au; Roberto A Abbiati; M Guillaume Wientjes; Ze Lu
Journal:  Pharmacol Rev       Date:  2019-04       Impact factor: 25.468

8.  Early aggregation steps in alpha-synuclein as measured by FCS and FRET: evidence for a contagious conformational change.

Authors:  Sangeeta Nath; Jessika Meuvis; Jelle Hendrix; Shaun A Carl; Yves Engelborghs
Journal:  Biophys J       Date:  2010-04-07       Impact factor: 4.033

9.  NF-κB decoy polyplexes decrease P-glycoprotein-mediated multidrug resistance in colorectal cancer cells.

Authors:  N H Abd Ellah; L Taylor; N Ayres; M M Elmahdy; G N Fetih; H N Jones; E A Ibrahim; G M Pauletti
Journal:  Cancer Gene Ther       Date:  2016-04-29       Impact factor: 5.987

10.  The efficacy of nuclease-resistant Chol-siRNA in primary breast tumors following complexation with PLL-PEG(5K).

Authors:  Vishakha V Ambardekar; Rajesh R Wakaskar; Bhawna Sharma; Joy Bowman; Willy Vayaboury; Rakesh K Singh; Joseph A Vetro
Journal:  Biomaterials       Date:  2013-04-01       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.